This new clinical program dedicated to Relapsing Polychondritis and VEXAS syndrome offers a groundbreaking approach to patient care, emphasizing the importance of multidisciplinary collaboration. This innovative program brings together specialists from various fields, including rheumatology, hematology, and pulmonology, to provide comprehensive and personalized treatment plans.
By fostering an integrated care environment, the program aims to enhance diagnostic accuracy, optimize therapeutic strategies, and improve overall patient outcomes.
Patients will benefit from the collective expertise and coordinated efforts of a diverse medical team, ensuring a holistic and patient-centered approach to managing these complex conditions
The program is run by Dr. Marcela Ferrada.
What is Relapsing Polychondritis?
Relapsing polychondritis is a rare, chronic disease characterized by recurrent inflammation of cartilage and other tissues throughout the body. Although it primarily affects the cartilage in the ears, nose, joints, and respiratory tract, relapsing polychondritis is a very heterogeneous disease that can impact other organs as well.
Symptoms include pain, redness, and swelling, and over time, inflammation can cause progressive damage to the affected cartilage, potentially resulting in deformities and functional impairments.
Learn About Relapsing Polychondritis
Understanding VEXAS
VEXAS syndrome is a recently identified, rare, and severe hemato-inflammatory condition characterized by a unique set of symptoms, including recurrent fevers, inflammation of cartilage, skin rashes, and blood abnormalities.
This syndrome primarily affects middle-aged and older men, leading to significant morbidity due to its systemic nature.